DK1181038T3 - Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer - Google Patents
Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individerInfo
- Publication number
- DK1181038T3 DK1181038T3 DK00925098T DK00925098T DK1181038T3 DK 1181038 T3 DK1181038 T3 DK 1181038T3 DK 00925098 T DK00925098 T DK 00925098T DK 00925098 T DK00925098 T DK 00925098T DK 1181038 T3 DK1181038 T3 DK 1181038T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- mbl
- mannan
- prophylaxis
- binding lectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Filtering Materials (AREA)
- Wrappers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900668 | 1999-05-14 | ||
DKPA199901508 | 1999-10-20 | ||
EP00925098A EP1181038B1 (fr) | 1999-05-14 | 2000-05-10 | Nouvelles indications de lectine de liaison au mannane (mbl) dans le traitement d'individus immunodeprimes |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1181038T3 true DK1181038T3 (da) | 2004-08-09 |
Family
ID=26064419
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00925098T DK1181038T3 (da) | 1999-05-14 | 2000-05-10 | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer |
DK00925097T DK1181363T3 (da) | 1999-05-14 | 2000-05-10 | Rekombinant humant mannanbindende lectin |
DK03029993T DK1402897T3 (da) | 1999-05-14 | 2000-05-10 | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00925097T DK1181363T3 (da) | 1999-05-14 | 2000-05-10 | Rekombinant humant mannanbindende lectin |
DK03029993T DK1402897T3 (da) | 1999-05-14 | 2000-05-10 | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer |
Country Status (15)
Country | Link |
---|---|
US (5) | US6846649B1 (fr) |
EP (3) | EP1181038B1 (fr) |
JP (2) | JP2002544286A (fr) |
CN (2) | CN1359420A (fr) |
AT (3) | ATE336260T1 (fr) |
AU (2) | AU781135B2 (fr) |
CA (2) | CA2372435A1 (fr) |
DE (3) | DE60030173T2 (fr) |
DK (3) | DK1181038T3 (fr) |
ES (3) | ES2281341T3 (fr) |
NO (2) | NO20015481L (fr) |
NZ (2) | NZ515717A (fr) |
PT (3) | PT1402897E (fr) |
RU (2) | RU2292217C2 (fr) |
WO (2) | WO2000070043A1 (fr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6969601B2 (en) * | 1997-04-03 | 2005-11-29 | Jensenius Jens Chr | MASP-2, a complement-fixing enzyme, and uses for it |
DK1181038T3 (da) * | 1999-05-14 | 2004-08-09 | Steffen Thiel | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer |
EP1303288A1 (fr) * | 2000-07-13 | 2003-04-23 | Natimmune A/S | Traitement a la lectine de liaison au mannane d'infections chez les personnes traitees avec des inhibiteurs de tnf-$g(a) |
EP1186299A1 (fr) | 2000-09-12 | 2002-03-13 | Universitair Medisch Centrum Utrecht | Diagnostic, prévention et/ou traitement d' athérosclérose, infections et perturbations du système immunitaire |
CN1487839A (zh) * | 2000-11-27 | 2004-04-07 | ղ˹��C��ղ˹���˹ | 用作佐剂的集合素 |
WO2003010188A1 (fr) | 2001-07-23 | 2003-02-06 | Natimmune A/S | Production de lectines à masse moléculaire élevée |
WO2003018617A1 (fr) * | 2001-08-31 | 2003-03-06 | Fuso Pharmaceutical Industries, Ltd. | Procede de purification de lectine liant le mannose humain, compositions de lectine liant le mannose humain et utilisation medicale de la lectine liant le mannose humain |
DE60207678T2 (de) * | 2001-10-19 | 2006-08-24 | Natimmune A/S | Isolierung von lectinen |
ATE337014T1 (de) * | 2002-03-15 | 2006-09-15 | Natimmune As | Mannose-bindungsprotein enthaltende pharmazeutische zusammensetzungen |
US7211396B2 (en) * | 2002-04-18 | 2007-05-01 | Antibodyshop A/S | Antibody pairs and kits for immunochemical determination of mannan-binding lectin |
EP1501537A4 (fr) * | 2002-04-24 | 2008-01-16 | Queensland Inst Med Res | Lectine de fixation du mannose et utilisations correspondantes |
AU2003246119B2 (en) * | 2002-06-28 | 2008-02-21 | Fuso Pharmaceutical Industries, Ltd. | Anti-HIV agent |
ATE349538T1 (de) * | 2002-09-10 | 2007-01-15 | Natlmmune As | Collectin-komplement aktivierende proteinchimären |
GB0222014D0 (en) * | 2002-09-23 | 2002-10-30 | Leuven K U Res & Dev | Mannan-binding lectin |
JP2007525232A (ja) | 2003-01-17 | 2007-09-06 | イースロン メディカル インコーポレイテッド | レクチンアフィニティー血液透析による血液のウイルス除去方法 |
PT2374819T (pt) | 2003-05-12 | 2017-07-04 | Helion Biotech Aps | Anticorpos para masp-2 |
US7135338B2 (en) * | 2003-06-11 | 2006-11-14 | Dobeel Corporation | Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
DE20317914U1 (de) | 2003-11-19 | 2004-12-30 | Weh, Erwin | Betätigungsvorrichtung für eine Schnellanschlusskupplung |
US7335633B2 (en) | 2004-01-12 | 2008-02-26 | Cornell Research Foundation, Inc. | Detecting recurrent vulvovaginal candidiasis or vulvar vestibulitis syndrome and method for treating same |
JP4884367B2 (ja) * | 2004-02-24 | 2012-02-29 | アボット・ヘルスケア・プロダクツ・ベスローテン・フェンノートシャップ | 神経疾患を発症する危険性を決定するための方法 |
EP1730176A2 (fr) * | 2004-03-09 | 2006-12-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Mvl, proteine antivirale issue d'une cyanobacterie |
US7919094B2 (en) * | 2004-06-10 | 2011-04-05 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
EP1618887A1 (fr) * | 2004-07-12 | 2006-01-25 | UMC Utrecht Holding B.V. | Epuration de polyols du corps |
US20090247454A1 (en) * | 2004-09-29 | 2009-10-01 | Mellitus, S.L. | Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease |
DE602005026705D1 (de) * | 2004-12-23 | 2011-04-14 | Council Scient Ind Res | Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose |
CN101094651B (zh) * | 2004-12-30 | 2011-03-09 | 多贝尔有限公司 | 含有胶原凝集素家族蛋白质或者其变体的喷雾干燥的组合物和其制备方法 |
US20080214435A1 (en) * | 2005-04-11 | 2008-09-04 | Natlmmune A/S | Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals |
WO2007044642A2 (fr) | 2005-10-06 | 2007-04-19 | President And Fellows Of Harvard College And Children's Medical Center Corporation | Dispositif et procede destines a la separation microfluidique-micromagnetique combinee d'une substance a partir d'un ecoulement continu |
ATE516043T1 (de) | 2005-12-21 | 2011-07-15 | Pharming Intellectual Pty Bv | Verwendung von c1-inhibitor zur prävention von ischämischen reperfusionsschäden |
WO2007085057A1 (fr) * | 2006-01-25 | 2007-08-02 | The Council Of The Queensland Institute Of Medical Research | Protocole médical |
US20070226567A1 (en) * | 2006-03-23 | 2007-09-27 | Gorman Kevin W | High speed bist utilizing clock multiplication |
CN101939531A (zh) * | 2008-01-16 | 2011-01-05 | 苏佩尔帕尔汽车工业和贸易有限公司 | 用于重型发动机平台的电动燃料泵 |
WO2009126346A2 (fr) * | 2008-01-18 | 2009-10-15 | The General Hospital Corporation | Procédés de prévention et de traitement d’infections au moyen de doses supraphysiologiques de lectine de liaison au mannane (mbl) et de protéines de fusion ficoline-mbl |
WO2010123594A2 (fr) | 2009-01-15 | 2010-10-28 | Children's Medical Center Corporation | Dispositif pour la filtration de fluides à travers celui-ci et procédé associé |
CA2787376A1 (fr) | 2010-01-19 | 2011-07-28 | President And Fellows Of Harvard College | Opsonine obtenue par genie genetique, pour la detection et le traitement de micro-organismes pathogenes |
WO2011100528A2 (fr) | 2010-02-12 | 2011-08-18 | Emory University | Compositions et utilisations de lectines |
DE102011003478A1 (de) * | 2011-02-01 | 2012-08-02 | Cytavis Biopharma Gmbh | Antivirales Mittel enthaltend rekombinante Mistellektine |
EP3081937B1 (fr) | 2011-07-18 | 2019-11-13 | President and Fellows of Harvard College | Molécules de ciblage de microbe modifiées et leurs utilisations |
CA2865744A1 (fr) | 2012-02-29 | 2013-09-06 | President And Fellows Of Harvard College | Test rapide de sensibilite aux antibiotiques |
WO2014014788A2 (fr) | 2012-07-18 | 2014-01-23 | President And Fellows Of Harvard College | Modification de surfaces pour une répulsion et une liaison ciblée simultanées de fractions désirées |
WO2014144325A1 (fr) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Procédés et compositions pour améliorer la détection et/ou la capture d'une entité cible |
EP3010522B1 (fr) | 2013-05-21 | 2021-01-20 | President and Fellows of Harvard College | Compositions se liant à l'hème manipulées et leurs utilisations |
WO2015095604A2 (fr) | 2013-12-18 | 2015-06-25 | President And Fellows Of Harvard College | Méthodes et analyses associées à des cellules tumorales circulantes |
US10357780B2 (en) | 2014-10-27 | 2019-07-23 | President And Fellows Of Harvard College | Magnetic capture of a target from a fluid |
CN108289928A (zh) | 2015-08-06 | 2018-07-17 | 哈佛大学校长及研究员协会 | 改进的微生物-结合分子和其用途 |
US11919971B2 (en) | 2016-05-16 | 2024-03-05 | President And Fellows Of Harvard College | Aqueous biomolecule coupling on CO2-plasma-activated surfaces |
CN107050427A (zh) * | 2017-02-27 | 2017-08-18 | 新乡医学院 | MBL在制备预防或治疗以Tregs为靶点的疾病药物中的应用 |
CN107050436B (zh) * | 2017-02-27 | 2020-03-17 | 新乡医学院 | Mbl在制备预防或治疗效应t细胞引发疾病药物中的应用 |
WO2019110706A1 (fr) * | 2017-12-08 | 2019-06-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés de prédiction de risque de développement d'une sepsie ou d'un syndrome de réponse inflammatoire systémique (sirs) |
RU2739113C1 (ru) * | 2019-10-04 | 2020-12-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр терапии и профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТПМ" Минздрава России) | Способ определения активности маннан-связывающих лектин-ассоциированных сериновых протеаз в тесте коагуляции фибриногена |
WO2023087090A1 (fr) * | 2021-11-18 | 2023-05-25 | Magellan Therapeutics Inc. | Protéines recombinantes |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270199A (en) | 1987-08-20 | 1993-12-14 | The Children's Medical Center Corporation | Human mannose-binding protein |
DE3856180T2 (de) * | 1987-08-20 | 1998-09-03 | Childrens Medical Center | Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren |
US5112952A (en) | 1990-09-28 | 1992-05-12 | Pierce Chemical Company | Composition and method for isolation and purification of Immunoglobulin M |
WO1997007210A1 (fr) | 1995-08-17 | 1997-02-27 | Fuso Pharmaceutical Industries, Ltd. | Conglutinine recombinee et son procede de production |
EP1008351B1 (fr) | 1997-08-21 | 2006-11-15 | Takara Bio Inc. | Agents cancerostatiques |
DK1084143T3 (da) * | 1998-06-10 | 2006-12-27 | Statens Seruminstitut | Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt |
DK1181038T3 (da) * | 1999-05-14 | 2004-08-09 | Steffen Thiel | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer |
-
2000
- 2000-05-10 DK DK00925098T patent/DK1181038T3/da active
- 2000-05-10 EP EP00925098A patent/EP1181038B1/fr not_active Expired - Lifetime
- 2000-05-10 ES ES00925097T patent/ES2281341T3/es not_active Expired - Lifetime
- 2000-05-10 US US09/568,143 patent/US6846649B1/en not_active Expired - Fee Related
- 2000-05-10 NZ NZ515717A patent/NZ515717A/xx unknown
- 2000-05-10 CA CA002372435A patent/CA2372435A1/fr not_active Abandoned
- 2000-05-10 DE DE60030173T patent/DE60030173T2/de not_active Expired - Fee Related
- 2000-05-10 CN CN00809713A patent/CN1359420A/zh active Pending
- 2000-05-10 CA CA002372128A patent/CA2372128A1/fr not_active Abandoned
- 2000-05-10 RU RU2001133343/15A patent/RU2292217C2/ru active
- 2000-05-10 JP JP2000618310A patent/JP2002544286A/ja active Pending
- 2000-05-10 PT PT03029993T patent/PT1402897E/pt unknown
- 2000-05-10 DK DK00925097T patent/DK1181363T3/da active
- 2000-05-10 DE DE60033147T patent/DE60033147T2/de not_active Expired - Fee Related
- 2000-05-10 EP EP00925097A patent/EP1181363B1/fr not_active Expired - Lifetime
- 2000-05-10 CN CN00809714A patent/CN1359298A/zh active Pending
- 2000-05-10 AU AU43935/00A patent/AU781135B2/en not_active Ceased
- 2000-05-10 AT AT03029993T patent/ATE336260T1/de not_active IP Right Cessation
- 2000-05-10 ES ES00925098T patent/ES2219336T3/es not_active Expired - Lifetime
- 2000-05-10 NZ NZ515718A patent/NZ515718A/xx unknown
- 2000-05-10 AU AU43936/00A patent/AU779404B2/en not_active Ceased
- 2000-05-10 DK DK03029993T patent/DK1402897T3/da active
- 2000-05-10 WO PCT/DK2000/000246 patent/WO2000070043A1/fr active IP Right Grant
- 2000-05-10 PT PT00925098T patent/PT1181038E/pt unknown
- 2000-05-10 WO PCT/DK2000/000247 patent/WO2000069894A2/fr active IP Right Grant
- 2000-05-10 ES ES03029993T patent/ES2271468T3/es not_active Expired - Lifetime
- 2000-05-10 PT PT00925097T patent/PT1181363E/pt unknown
- 2000-05-10 AT AT00925097T patent/ATE352620T1/de not_active IP Right Cessation
- 2000-05-10 JP JP2000618449A patent/JP2002543837A/ja active Pending
- 2000-05-10 EP EP03029993A patent/EP1402897B1/fr not_active Expired - Lifetime
- 2000-05-10 DE DE60009896T patent/DE60009896T2/de not_active Expired - Fee Related
- 2000-05-10 AT AT00925098T patent/ATE264111T1/de not_active IP Right Cessation
- 2000-05-10 US US09/568,142 patent/US6562784B1/en not_active Expired - Fee Related
-
2001
- 2001-11-08 NO NO20015481A patent/NO20015481L/no unknown
- 2001-11-09 NO NO20015506A patent/NO20015506L/no not_active Application Discontinuation
-
2003
- 2003-04-29 US US10/424,769 patent/US7202207B2/en not_active Expired - Fee Related
- 2003-12-03 US US10/725,412 patent/US20040229212A1/en not_active Abandoned
-
2005
- 2005-08-12 RU RU2005125625/14A patent/RU2005125625A/ru not_active Application Discontinuation
-
2007
- 2007-03-27 US US11/727,461 patent/US7439224B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1402897T3 (da) | Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
SE0102315D0 (sv) | Compounds | |
MA27998A1 (fr) | Nouvelle formulation | |
HUP0103889A2 (hu) | Kopolimer-1-rokon polipeptidek alkalmazása molekulatömeg kalibráló standardként és gyógyászati anyagként | |
MY106315A (en) | Pharmaceutical agents | |
DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
HUP0300725A2 (hu) | Az inzulinrezisztencia-szindróma kezelése CGMP PDE5 inhibitorokkal | |
ATE291424T1 (de) | Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung | |
BG105302A (en) | Means for improving cognition | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
ATE407947T1 (de) | Proteine mit il-6 inhibitorischer wirkung | |
ATE313562T1 (de) | Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
NO20032597D0 (no) | Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma | |
FR2710844B1 (fr) | Composition pour le traitement ou la prévention de l'herpès. | |
NZ228068A (en) | Brominated or chlorinated allylamines and their pharmaceutical compositions | |
DE60003074D1 (de) | Fusidinsäure-derivate | |
EP1370697A4 (fr) | Medicaments a base de peroxyredoxine pour le traitement d'infections par le vih-1, et leurs methodes d'utilisation | |
MXPA04006120A (es) | Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3. | |
WO2002097075A3 (fr) | Enzyme de coiffage du flavivirus et utilisation de cette proteine dans un processus de test de medicaments ayant des proprietes antivirales | |
HUP0402645A2 (hu) | Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére | |
ES2127133A1 (es) | Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer. | |
PT1355650E (pt) | Combinacao de ingredientes activos contendo alfuzosina e apomorfina |